BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 8620323)

  • 1. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
    Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
    Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
    Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
    Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
    Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
    J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitides--immunologic and clinical aspects.
    Schulz JI
    Bratisl Lek Listy; 1995 Oct; 96(10):520-2. PubMed ID: 8620321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
    Savige JA; Chang L; Wilson D; Buchanan RR
    Rheumatol Int; 1996; 16(3):109-14. PubMed ID: 8893375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The spectrum of diseases associated with antineutrophil cytoplasmic antibodies].
    Bartůnková J; Janatková I; Tesar V; Rychlík I; Poch T; Krystůfková O; Zabka J
    Cas Lek Cesk; 1995 Jan; 134(1):18-21. PubMed ID: 7712518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.
    Saito R; Watanabe H; Asano T; Suzuki E; Iwadate H; Kobayashi H; Ohira H
    Int J Rheum Dis; 2013 Jun; 16(3):339-46. PubMed ID: 23981757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineutrophil cytoplasmic antibodies].
    Sebastiani GD
    Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
    Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
    Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibodies.
    Bosch X; Guilabert A; Font J
    Lancet; 2006 Jul; 368(9533):404-18. PubMed ID: 16876669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies (ANCA).
    Radice A; Sinico RA
    Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.